Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: First report from the ISOBM TD-1 workshop

Tumor Biology

Volumn 17, Issue 4, 1996, Pages 196-219

  Nustad, K ^a   Bast, R C ^b   O'brien T J ^c   Nilsson, O ^d   Seguin, P ^e   Suresh, M R ^f   Saga, T ^h   Nozawa, S ^h   Bormer O P ^a   de Bruijn, H W A ⁱ   Nap, M ^j   Vitali, A ^k   Gadnell, M ^l   Clark, J ^c   Shigemasa, K ^c   Karlsson, B ^d   Kreutz, F T ^f   Jette, D ^f   Sakahara, H ^g   Endo, K ^m   Paus, E ^a   Warren, D ^a   Hammarstrom S ⁿ   Kenemans, P ^o   Hilgers, J ^o   more..

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d Fujirebio Diagnostics Inc   (Sweden)

^e CIS Bio International   (France)

^f UNIVERSITY OF ALBERTA   (Canada)

^g KYOTO UNIVERSITY HOSPITAL   (Japan)

^h KEIO UNIVERSITY   (Japan)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j Lab V Volksgezondheid in Friesland   (Netherlands)

^k Ospetale St Corona ^*  (Italy)

^l BIACORE AB   (Sweden)

^m GUNMA UNIVERSITY HOSPITAL   (Japan)

ⁿ UMEÅ UNIVERSITY   (Sweden)

^o VU UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Antibodies, monoclonal; Antibody affinity; Antibody specificity; CA 125 antigen; Epitope mapping; Tumor marker

Indexed keywords

CA 125 ANTIGEN; EPITOPE; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUMOR MARKER;

ANTIBODY AFFINITY; CONFERENCE PAPER; HUMAN; OVARY CANCER; PRIORITY JOURNAL;

EID: 8944237522     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000217982     Document Type: Article

References (31)

1. Bast RC Jr., Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC: Reactivity of a monoclonal antibody with human ovarian carcinoma, J Clin Invest 1981:68:1331-1337.
2. Bast RC Jr., Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR Jr., Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer, N Engl J Med 1983; 309:883-887.
3. Nouwen EI, Hendrix PG, Dauwe S, Eerdekens MW, De Broc ME: Tumor markers in the human ovary and its neoplasms, A comparative immunohistochemical study, Am J Pathol 1987;126:230-242.
4. Zrawski VR Jr., Davis HM, Finkler NJ, Harrison CL, Bast RC Jr., Knapp RC: Tissue distribution and characteristics of the CA 125 antigen, Cancer Rev 1988;11/12:102-118.
5. Hardardottir H, Parmley TH, Quirk JG Jr., Sanders MM, Miller FC, O’brien TJ: Distribution of CA 125 in embryonic tissues and adult derivatives of the fetal periderm, Am J Obstet Gynecol 1990; 163:1925-1931.
6. Kuzuya K, Nozaki M, Chihara T: Evaluation of CA125 as a circulating tumor marker for ovarian cancer, Nippon Sanka Fujinka Gakkai Zasshi 1986;38:949-957.
7. Kenemans P, Yedema CA, Bon GG, von Mensdorff-Pouilly S: CA 125 in gynecological pathology-a review, Eur J Obstct Gynecol Reprod Biol 1993;49:115-124.
8. Dc Bruijn HWA, van Beeck Calkoen-Carpay T, Jager S, Duk JM, Aalders JG, Fleuren GJ: The tumor marker CA 125 is a common constituent of normal cervical mucus, Am J Obstct Gynecol 1986:154: 1088-1091.
9. Niloff JM, Knapp RC, Schactzl E, Reynolds C, Bast RC Jr.: CA125 antigen levels in obstetric and gynecologic patients, Obstct Gynecol 1984: 64:703-707.
10. O’brien TJ, Hardin JW, Bannon GA, Norris JS, Quirk JG Jr.: CA 125 antigen in human amniotic fluid and fetal membranes, Am J Obstet Gynecol 1986:155:50-55.
11. Hanisch F-G, Uhlenbruck G, Dienst C, Stottrop M, Hippauf E: Ca 125 and Ca 19-9: two cancer-associated sialylsaccaride antigens on a mucus glycoprotein from human milk, Eur J Biochem 1985;149:323-330.
12. Fleuren GJ, Nap M, Aalders JG, Trimbos JB, de Bruijn HWA: Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors, Cancer 1987:60:2437-2442.
13. Masuho Y, Zalutsky M, Knapp RC, Bast RC Jr.: Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas, Cancer Res 1984:44: 2813-2819.
14. Halila H: Detection of ovarian cancer marker CA 125 in human seminal plasma, Tumour Biol 1985:6: 207-212.
15. Davis HM, Zurawski VR Jr., Bast RC Jr., Klug TL: Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas, Cancer Res 1986:46:6143-6148.
16. Leoni F, Bast RC Jr., Canevari S, Menard S, Soper JT, Colnaghi MI: Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancer, Int J Cancer 1987:40:592-597.
17. Matsuoka Y, Nakashima T, Endo K, Yoshida T, Kunimatsu M, Sakahara H, Koizumi M, Nakagawa T, Yamaguchi N, Torizuka K: Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization oflungcancer cells, Cancer Res 1987:47:6335-6340.
18. de los Frailes MT, Stark S, Jaeger W, Hocrauf A, Wildt L: Purification and characterization of the CA 125 tumor-associated antigen from human ascites, Tumor Biol 1993; 14:18-29.
19. Intai S, Maeda H, Kiyozuka Y, Mo-rimoto J, Haga S, Noda T, Hiroishi S, Hilgers J: Monoclonal antibodies against CA 125-bearing antigenic molecule fragments; reactivity with mucinous ovarian tumours and lung cancers, MolCell Probes 1991:5:55-63.
20. Nagata A, Hirota N, Sakai T, Fuji-moto M, Komoda T: Molecular nature and possible presence of a membraneous glycan-phosphalidyl-inositol anchor of CA125 antigen, Tumor Biol 1991:12:279-286.
21. Fendrick JL, Staley KA, Gee MK, McDougald SR, Quirk JG Jr., O’Brien TJ: Characterization of CA 125 synthesized by the human epithelial amnion WISH cell line, Tumor Biol 1993;14:310-318.
22. Konishi I, Fendrick JL, Parmley TH, Quirk JG Jr., O’Brien TJ: Epidermal growth factor enhances secretion of the ovarian tumor-asso-siated antigen CA125 from the human amnion WISH cell line, J Soc Gynecol Invest 1994;1:89-96.
23. Kenemans P, van Karnp GJ, Oehr P, Verstraeten RA: Heterologous double-determinant immunoradio-metric assay CA 125II: Reliable second-generation immunoassay for determining CA 125 in serum, Clin Chem 1993;39:2509-2513.
24. Hammarstrom S, Shively JE, Paxton RJ, Beatty BG, l-arsson A, Ghosh R, Bormcr O, Bucheggcr F, Mach J-P, Burtin P, Seguin P, Dar-bouret B, Degorce F, Scrtour J, Jolu JP, Fuks A, Kalthoff H, Schmiegel W, Arndt R, Kloppel G, von Klcist S, Gruncrt F, Schwarz K, Matsuoka Y, Kuroki M, Wagencr C, Weber T, Yachi A, Imai K, Hishikawa N, Tsu-jisaki M: Antigenic sites in carci-noembryonic antigen, Cancer Res 1989:49:4852-4858.
25. Nap M, Hammarstrom M-L, Bor-mer O, Hammarstrom S, Wagencr C, Handl S, Schreyer M, Mach J-P, Buchegger F, von Kleist S, Grunert F, Seguin P, Fucks A, Holm R, La-merz R: Specificity and affinity of monoclonal antibodies against car-cinocmbryonic antigen, Cancer Res 1992:52:2329-2339.
26. N’ustad K, Nilsson O, Kierulf B, Varaas T, Thrane-Steen K, Paus E, Okkenhaug C, Olsen KH, Bormer OP: Immunoassays for the CA 125-rclat-ed antigen using new monoclonal antibodies; in Klapdor R (ed): Current Tumor Diagnosis: Applications, Clinical Relevance, Research, Trends, Miinchen, Zuckschwerdt, 1994. pp 397-400.
27. O’Brien TJ, Raymond LM, Bannon GA, Ford DH, Hardardottir H, Miller FC, Quirk JG Jr.: New monoclonal antibodies identify the glycoprotein carrying the C’A 125 epitope, Am J Obstet Gynecol 1991:165: 1857-1864.
28. Nilsson O, Jansson E-L, Dahlen U, Nilsson K, Nustad K, Hogberg T, Lindholm L: New monoclonal antibodies for determination of the ovarian cancer associated antigen CA 125; in Klapdor R (ed): Current Tumor Diagnosis: Applications, Clinical Relevance, Research, Trends, Miinchen, Zuckschwerdt, 1994. pp 401-405.
29. Capstiek V, MacLcan GD, Suresh MR, Bodnar D, Lloyd S, Shepert L, Longeneckcr BM, Krantz M: Clinical evaluation of a new two-site assay for CA125 antigen, Int J Biol Markers 1991;6:129-135.
30. Nozawa S, Yajima M, Sasaki H, Tsukazaki K, Aoki D, Sakayori M, Udagawa Y, Kobayashi T, Sato I, Furusako S, Mochizuki H: A new CA125-likc antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II), Jpn J Cancer Res 1991:82:854-861.
31. Saga T, Endo K, Nakashima T, Awaji T, Koizumi M, Kawamura Y, Watanabe Y, Konishi J, Nonogaki H, Nanbu Y, Fujii S, Mori T: Construction of an immunoradiometric assay for ovarian cancer associated antigen CA 125 recognizing different antigenic determinant, Acta Obstet Gynecol Scand 1990;69:175-181.